nach oben

Quality of Life Research

Erschienen in:

23.07.2018

Evaluation of opioid use among patients with back disorders and arthritis

verfasst von: Corey J. Hayes, Nalin Payakachat, Chenghui Li

Erschienen in: Quality of Life Research | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Long-term opioid use for chronic pain has increased, but limited evidence exists on its benefits. Evaluation of long-term benefits in pain is based on patient-reported measures such as health-related quality of life (HRQoL). This study examined the long-term effects of opioid use on HRQoL and its subdomains in patients with back pain or arthritis by comparing opioid users to non-opioid users for three metrics: (1) any opioid use, (2) duration of opioid use, and (3) average daily morphine equivalent dose.

Methods

A nationally representative sample of cancer-free adults with chronic back pain or arthritis was selected. Using the 12-Item Short Form Survey, HRQoL measures of Mental Component Score (MCS), Physical Component Score (PCS), and individual subdomains were assessed at baseline and 1 year later. Opioid users were matched to non-opioid users in a 1:1 greedy match using propensity scores estimated based on many patient demographics and baseline HRQoL measures.

Results

At year one, PCS was significantly lower among opioid users, mostly driven by bodily pain subdomain; MCS was not different. Short-term opioid users (< 1 month) had higher MCS while long-term users (≥ 1 month) had lower PCS. Low-dose [< 20 morphine milligram equivalents (MME)/day] opioid use was associated with lower PCS, while no difference was found between high dose (≥ 20 MME/day) and non-opioid users. However, most differences were not clinically significant.

Conclusions

Long-term opioid use is not associated with improvements in HRQoL. Clinicians should carefully evaluate the need for opioid use, especially long-term use in managing chronic back pain and arthritis.

Nur mit Berechtigung zugänglich

Hootman, J. M., Helmick, C. G., Barbour, K. E., Theis, K. A., & Boring, M. A. (2016). Updated projected prevalence of self-reported doctor-diagnosed arthritis and arthritis-attributable activity limitation among US adults, 2015–2040. Arthritis & Rheumatology (Hoboken, N.J.), 68(7), 1582–1587. https://doi.org/10.1002/art.39692.CrossRef

Freburger, J. K., Holmes, G. M., Agans, R. P., Jackman, A. M., Darter, J. D., Wallace, A. S., et al. (2009). The rising prevalence of chronic low back pain. Archives of Internal Medicine, 169(3), 251–258. https://doi.org/10.1001/archinternmed.2008.543.CrossRefPubMedPubMedCentral

Landsman-Blumberg, P. B., Katz, N., Gajria, K., D’Souza, A. O., Chaudhari, S. L., Yeung, P. P., et al. (2017). Health care resource use and cost differences by opioid therapy type among chronic noncancer pain patients. Journal of Pain Research, 10, 1713–1722. https://doi.org/10.2147/JPR.S130913.CrossRefPubMedPubMedCentral

Zamora-Legoff, J. A., Achenbach, S. J., Crowson, C. S., Krause, M. L., Davis, J. M., & Matteson, E. L. (2016). Opioid use in patients with rheumatoid arthritis 2005–2014: A population-based comparative study. Clinical Rheumatology, 35(5), 1137–1144. https://doi.org/10.1007/s10067-016-3239-4.CrossRefPubMedPubMedCentral

Wright, E. A., Katz, J. N., Abrams, S., Solomon, D. H., & Losina, E. (2014). Trends in prescription of opioids from 2003 to 2009 in persons with knee osteoarthritis. Arthritis Care & Research, 66(10), 1489–1495. https://doi.org/10.1002/acr.22360.CrossRef

Mafi, J. N., McCarthy, E. P., Davis, R. B., & Landon, B. E. (2013). Worsening trends in the management and treatment of back pain. JAMA Internal Medicine, 173(17), 1573. https://doi.org/10.1001/jamainternmed.2013.8992.CrossRefPubMedPubMedCentral

Chaparro, L. E., Furlan, A. D., Deshpande, A., Mailis-Gagnon, A., Atlas, S., & Turk, D. C. (2014). Opioids compared with placebo or other treatments for chronic low back pain. Spine, 39(7), 556–563. https://doi.org/10.1097/BRS.0000000000000249.CrossRefPubMed

Chou, R., Rick Deyo, F., Beth Devine, M., Ryan Hansen, R., Sullivan, S., Jarvik, J. G., et al. (2014). The effectiveness and risks of long-term opioid treatment of chronic pain. Rockville, MD: Agency for Healthcare Research and Quality (US).CrossRef

Breivik, H., Borchgrevink, P. C., Allen, S. M., Rosseland, L. A., Romundstad, L., Breivik Hals, E. K., et al.(2008). Assessment of pain. British Journal of Anaesthesia, 101(1), 17–24. https://doi.org/10.1093/bja/aen103.CrossRefPubMed

10.

Katz, N. (2002). The impact of pain management on quality of life. Journal of Pain and Symptom Management, 24(1), S38–S47. https://doi.org/10.1016/S0885-3924(02)00411-6.CrossRefPubMed

11.

Agency for Healthcare Research and Quality. (n.d.). Medical Expenditure Panel Survey background. Retrieved August 10, 2016, from https://meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp.

12.

Agency for Healthcare Research and Quality. (n.d.). Medical Expenditure Panel Survey home. Retrieved May 3, 2016, from http://meps.ahrq.gov/mepsweb/.

13.

Medical Expenditure Panel Survey Public Use File Search Results. (n.d.). Retrieved January 11, 2017, from https://meps.ahrq.gov/mepsweb/data_stats/download_data_files_results.jsp?cboDataYear=All&cboDataTypeY=1%2CHousehold+Full+Year+File&buttonYearandDataType=Search&cboPufNumber=All&SearchTitle=Medical+Conditions

14.

Multum Source Information. (n.d.). Retrieved from https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/MMSL/.

15.

Lemke, M. (2015). Prescription opioid use in the U.S. in 2012: Characterizing sustained vs. infrequent use using the medical expenditure panel survey. Retrieved from http://www.lexjansen.com/sesug/2015/182_Final_PDF.pdf.

16.

Stockbridge, E. L., Suzuki, S., & Pagán, J. A. (2015). Chronic pain and health care spending: An analysis of longitudinal data from the Medical Expenditure Panel Survey. Health Services Research, 50(3), 847–870. https://doi.org/10.1111/1475-6773.12263.CrossRefPubMed

17.

IMS Health. (n.d.). IMS LifeLink Health Plan Claims Database: Overview and study design issues. Retrieved November 21, 2015, from http://www.uams.edu/TRI/hsrcore/Lifelink_Health_Plan_Claims_Data_DesignIssues_wcost_April2010%5B1%5D.pdf.

18.

U.S Department of Justice Drug Enforcement Administration Office of Diversion Control. (2014). Rules—2014—Final rule: Rescheduling of hydrocodone combination products from schedule III to schedule II. Retrieved August 11, 2016, from http://www.deadiversion.usdoj.gov/fed_regs/rules/2014/fr0822.htm.

19.

Shah, A., Hayes, C. J., & Martin, B. C. (2017). Characteristics of initial prescription episodes and likelihood of long-term opioid use — United States, 2006–2015. MMWR Morbidity and Mortality Weekly Report, 66(10), 265–269. https://doi.org/10.15585/mmwr.mm6610a1.CrossRefPubMedPubMedCentral

20.

Hayes, C. J., Hudson, T. J., Phillips, M. M., Bursac, Z., Williams, J. S., Austin, M. A., et al. (2015). The influence of propoxyphene withdrawal on opioid use in veterans. Pharmacoepidemiology and Drug Safety, 24(11), 1180–1188. https://doi.org/10.1002/pds.3851.CrossRefPubMedPubMedCentral

21.

Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR. Recommendations and Reports, 65(1), 1–49. https://doi.org/10.15585/mmwr.rr6501e1er.CrossRefPubMed

22.

Hayes, C., Bhandari, N., Kathe, N., & Payakachat, N. (2017). Reliability and Validity of the medical outcomes study short form-12 version 2 (SF-12v2) in adults with non-cancer pain. Healthcare, 5(2), 22. https://doi.org/10.3390/healthcare5020022.CrossRefPubMedCentral

23.

Ware, J. (2005). How to score version 2 of the SF-12 health survey (with a supplement documenting version 1). Lincoln, RI: QualityMetric Inc.

24.

Cheak-Zamora, N. C., Wyrwich, K. W., & McBride, T. D. (2009). Reliability and validity of the SF-12v2 in the medical expenditure panel survey. Quality of Life Research, 18(6), 727–735. https://doi.org/10.1007/s11136-009-9483-1.CrossRefPubMed

25.

Weblet Importer. (n.d.). Retrieved November 15, 2017, from http://gim.med.ucla.edu/FacultyPages/Hays/utils/sf12v2-1.sas.

26.

Ward, M. M., Guthrie, L. C., & Alba, M. I. (2014). Clinically important changes in short form 36 health survey scales for use in rheumatoid arthritis clinical trials: The impact of low responsiveness. Arthritis Care & Research, 66(12), 1783–1789. https://doi.org/10.1002/acr.22392.CrossRef

27.

Díaz-Arribas, M. J., Fernández-Serrano, M., Royuela, A., Kovacs, F. M., Gallego-Izquierdo, T., Ramos-Sánchez, M., et al. (2017). Minimal clinically important difference in quality of life for patients with low back pain. SPINE. https://doi.org/10.1097/BRS.0000000000002298.CrossRefPubMed

28.

Escobar, A., Quintana, J. M., Bilbao, A., Aróstegui, I., Lafuente, I., & Vidaurreta, I. (2007). Responsiveness and clinically important differences for the WOMAC and SF-36 after total knee replacement. Osteoarthritis and Cartilage, 15(3), 273–280. https://doi.org/10.1016/j.joca.2006.09.001.CrossRefPubMed

29.

Cohen, J. (1977). Statistical power analysis for the behavioral sciences. New York: Academic Press.

30.

SF-12v2^TM Health Survey. (n.d.). Retrieved from http://www.cscc.unc.edu/codi/forms/UNLICOMMSFHSF12ShortFormHealthSurvey03192010.pdf.

31.

Deyo, R. A., Cherkin, D. C., & Ciol, M. A. (1992). Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. Journal of Clinical Epidemiology, 45(6), 613–619.CrossRef

32.

Austin, P. C. (2008). Goodness-of-fit diagnostics for the propensity score model when estimating treatment effects using covariate adjustment with the propensity score. Pharmacoepidemiology and Drug Safety, 17(12), 1202–1217. https://doi.org/10.1002/pds.1673.CrossRefPubMed

33.

Austin, P. C. (2011). An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behavioral Research, 46(3), 399–424. https://doi.org/10.1080/00273171.2011.568786.CrossRefPubMedPubMedCentral

34.

LaValley, M. P. (2008). Logistic regression. Circulation, 117(18), 2395–2399. https://doi.org/10.1161/CIRCULATIONAHA.106.682658.CrossRefPubMed

35.

Hochberg, Y., & Benjamini, Y. (1990). More powerful procedures for multiple significance testing. Statistics in Medicine, 9(7), 811–818. https://doi.org/10.1002/sim.4780090710.CrossRefPubMed

36.

Whittle, S. L., Richards, B. L., & Buchbinder, R. (2013). Opioid analgesics for rheumatoid arthritis pain. JAMA, 309(5), 485. https://doi.org/10.1001/jama.2012.193412.CrossRefPubMed

37.

Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., et al. (2018). Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain. JAMA, 319(9), 872. https://doi.org/10.1001/jama.2018.0899.CrossRefPubMedPubMedCentral

38.

Sites, B. D., Beach, M. L., & Davis, M. A. (2014). Increases in the use of prescription opioid analgesics and the lack of improvement in disability metrics among users. Regional Anesthesia and Pain Medicine, 39(1), 6–12. https://doi.org/10.1097/AAP.0000000000000022.CrossRefPubMedPubMedCentral

39.

Bostick, G. P., Toth, C., Carr, E. C. J., Stitt, L. W., Morley-Forster, P., Clark, A. J., et al. (2015). Physical functioning and opioid use in patients with neuropathic pain. Pain Medicine (Malden, Mass.), 16(7), 1361–1368. https://doi.org/10.1111/pme.12702.CrossRef

40.

Warkentin, L. M., Majumdar, S. R., Johnson, J. A., Agborsangaya, C. B., Rueda-Clausen, C. F., Sharma, A. M., et al. (2014). Weight loss required by the severely obese to achieve clinically important differences in health-related quality of life: Two-year prospective cohort study. BMC Medicine, 12, 175. https://doi.org/10.1186/s12916-014-0175-5.CrossRefPubMedPubMedCentral

41.

Parker, S. L., Adogwa, O., Mendenhall, S. K., Shau, D. N., Anderson, W. N., Cheng, J. S., et al. (2012). Determination of minimum clinically important difference (MCID) in pain, disability, and quality of life after revision fusion for symptomatic pseudoarthrosis. The Spine Journal, 12(12), 1122–1128. https://doi.org/10.1016/j.spinee.2012.10.006.CrossRefPubMed

42.

Parker, S. L., Mendenhall, S. K., Shau, D., Adogwa, O., Cheng, J. S., Anderson, W. N., et al. (2012). Determination of minimum clinically important difference in pain, disability, and quality of life after extension of fusion for adjacent-segment disease. Journal of Neurosurgery: Spine, 16(1), 61–67. https://doi.org/10.3171/2011.8.SPINE1194.CrossRefPubMed

43.

Ashworth, J., Green, D. J., Dunn, K. M., & Jordan, K. P. (2013). Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? Pain, 154(7), 1038–1044. https://doi.org/10.1016/j.pain.2013.03.011.CrossRefPubMedPubMedCentral

44.

Dobscha, S. K., Lovejoy, T. I., Morasco, B. J., Kovas, A. E., Peters, D. M., Hart, K., et al. (2016). Predictors of improvements in pain intensity in a national cohort of older veterans with chronic pain. The Journal of Pain, 17(7), 824–835. https://doi.org/10.1016/j.jpain.2016.03.006.CrossRefPubMedPubMedCentral

45.

Benyamin, R., Trescot, A. M., Datta, S., Buenaventura, R., Adlaka, R., Sehgal, N., et al. (2008). Opioid complications and side effects. Pain Physician, 11(2 Suppl), S105–S120.PubMed

46.

Bartoli, A., Michna, E., He, E., & Wen, W. (2015). Pain intensity and interference with functioning and well-being in subgroups of patients with chronic pain treated with once-daily hydrocodone tablets. Journal of Opioid Management, 11(6), 519–533. https://doi.org/10.5055/jom.2015.0305.CrossRef

47.

Kea, B., Fu, R., Lowe, R. A., & Sun, B. C. (2016). Interpreting the national hospital ambulatory medical care survey: United States Emergency Department Opioid Prescribing, 2006–2010. Academic Emergency Medicine, 23(2), 159–165. https://doi.org/10.1111/acem.12862.CrossRefPubMedPubMedCentral

Titel: Evaluation of opioid use among patients with back disorders and arthritis
verfasst von: Corey J. Hayes
Nalin Payakachat
Chenghui Li
Publikationsdatum: 23.07.2018
Verlag: Springer International Publishing
Erschienen in: Quality of Life Research / Ausgabe 11/2018
Print ISSN: 0962-9343
Elektronische ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-018-1941-1

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2018

Comparison of health-related quality of life (HRQoL) between ileal conduit diversion and orthotopic neobladder based on validated questionnaires: a systematic review and meta-analysis

Correction to: Translation and cross-cultural adaptation of eight pediatric PROMIS® item banks into Spanish and German

Life satisfaction and pain interference in spine surgery patients before and after surgery: comparison between on-opioid and opioid-naïve patients

A triadic approach to health and dependence in aging adults: incongruence in perception

Psychiatric comorbidity and quality of life in South African alcohol use disorder patients

The reliability of end of day and ecological momentary assessments of pain and pain interference in individuals with spinal cord injury